YERXA BENJAMIN R
President
YERXA BENJAMIN R has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Oct 27, 2026.
On the most recent filing, YERXA BENJAMIN R is listed as President at Opus Genetics, Inc. Inside the rolling window, YERXA BENJAMIN R reported no open-market purchases and 3 open-market sales totaling $179K in IRD. The largest disclosed transaction in the window is a sale of 33,189 IRD shares on Oct 23, 2026, worth $117K.
Companies traded
Other insiders at IRD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$179K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has YERXA BENJAMIN R made?
YERXA BENJAMIN R has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does YERXA BENJAMIN R trade?
YERXA BENJAMIN R has filed SEC Form 4 disclosures for 1 company, including IRD.
When was YERXA BENJAMIN R's most recent SEC Form 4 filing?
YERXA BENJAMIN R's most recent SEC Form 4 filing on Tracefour is dated Oct 27, 2026.
What is YERXA BENJAMIN R's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, YERXA BENJAMIN R is listed as President.
What is YERXA BENJAMIN R's total buy and sell value in the current window?
Inside the rolling retention window, YERXA BENJAMIN R bought $0 and sold $179K based on SEC Form 4 filings.
What was YERXA BENJAMIN R's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 33,189 IRD shares on 2026-10-23, worth $117K, per SEC Form 4 filings.